CCG Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-786
| Closed | -$433K | – | 101 |
|
|
2022
Q4 | $433K | Buy |
786
+61
| +8% | +$33.6K | 0.24% | 45 |
|
|
2022
Q3 | $368K | Sell |
725
-73
| -9% | -$37.1K | 0.22% | 48 |
|
|
2022
Q2 | $434K | Buy |
798
+8
| +1% | +$4.35K | 0.24% | 47 |
|
|
2022
Q1 | $467K | Buy |
790
+249
| +46% | +$147K | 0.23% | 56 |
|
|
2021
Q4 | $361K | Hold |
541
| – | – | 0.19% | 53 |
|
|
2021
Q3 | $309K | Sell |
541
-1
| -0.2% | -$571 | 0.18% | 69 |
|
|
2021
Q2 | $273K | Buy |
+542
| New | +$273K | 0.21% | 50 |
|
|
2021
Q1 | – | Sell |
-443
| Closed | -$206K | – | 87 |
|
|
2020
Q4 | $206K | Sell |
443
-32
| -7% | -$14.9K | 0.22% | 74 |
|
|
2020
Q3 | $210K | Sell |
475
-105
| -18% | -$46.4K | 0.2% | 53 |
|
|
2020
Q2 | $210K | Buy |
+580
| New | +$210K | 0.2% | 51 |
|
|
2020
Q1 | – | Sell |
-700
| Closed | -$227K | – | 95 |
|
|
2019
Q4 | $227K | Sell |
700
-9
| -1% | -$2.92K | 0.14% | 85 |
|
|
2019
Q3 | $207K | Buy |
+709
| New | +$207K | 0.14% | 81 |
|